Xeris Biopharma Holdings (XERS)

• Market cap: $1.2B
• 1 day: 1.12%
• 5 days: -4.74%
• 1 month: -2.56%
• 3 months: -24.74%
• 6 months: 44.8%
• Year to date: -1.5%
• 1 year: 98.36%
• 5 years: 42.52%
• 10 years: -64.19%
• Sector: Healthcare
• Industry: Biotechnology

About: Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Employees: 394